Literature DB >> 34625494

Genomics serology to inform therapies and vaccines for arthritogenic alphaviruses.

Adolfo García-Sastre1,2,3,4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34625494      PMCID： PMC8590468          DOI： 10.1073/pnas.2114687118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  14 in total

1.  A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.

Authors:  Raffael Nachbagauer; Jodi Feser; Abdollah Naficy; David I Bernstein; Jeffrey Guptill; Emmanuel B Walter; Franceso Berlanda-Scorza; Daniel Stadlbauer; Patrick C Wilson; Teresa Aydillo; Mohammad Amin Behzadi; Disha Bhavsar; Carly Bliss; Christina Capuano; Juan Manuel Carreño; Veronika Chromikova; Carine Claeys; Lynda Coughlan; Alec W Freyn; Christopher Gast; Andres Javier; Kaijun Jiang; Chiara Mariottini; Meagan McMahon; Monica McNeal; Alicia Solórzano; Shirin Strohmeier; Weina Sun; Marie Van der Wielen; Bruce L Innis; Adolfo García-Sastre; Peter Palese; Florian Krammer
Journal:  Nat Med       Date:  2020-12-07       Impact factor: 53.440

2.  Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope.

Authors:  Arthur S Kim; Natasha M Kafai; Emma S Winkler; Theron C Gilliland; Emily L Cottle; James T Earnest; Prashant N Jethva; Paulina Kaplonek; Aadit P Shah; Rachel H Fong; Edgar Davidson; Ryan J Malonis; Jose A Quiroz; Lauren E Williamson; Lo Vang; Matthias Mack; James E Crowe; Benjamin J Doranz; Jonathan R Lai; Galit Alter; Michael L Gross; William B Klimstra; Daved H Fremont; Michael S Diamond
Journal:  Cell       Date:  2021-08-19       Impact factor: 66.850

3.  Antibody recognition of a highly conserved influenza virus epitope.

Authors:  Damian C Ekiert; Gira Bhabha; Marc-André Elsliger; Robert H E Friesen; Mandy Jongeneelen; Mark Throsby; Jaap Goudsmit; Ian A Wilson
Journal:  Science       Date:  2009-02-26       Impact factor: 47.728

4.  Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses.

Authors:  Ryan J Malonis; James T Earnest; Arthur S Kim; Matthew Angeliadis; Frederick W Holtsberg; M Javad Aman; Rohit K Jangra; Kartik Chandran; Johanna P Daily; Michael S Diamond; Margaret Kielian; Jonathan R Lai
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-14       Impact factor: 11.205

5.  A Review of Chikungunya Virus-induced Arthralgia: Clinical Manifestations, Therapeutics, and Pathogenesis.

Authors:  Brad A Goupil; Christopher N Mores
Journal:  Open Rheumatol J       Date:  2016-11-30

Review 6.  Neutralizing monoclonal antibodies for treatment of COVID-19.

Authors:  Peter C Taylor; Andrew C Adams; Matthew M Hufford; Inmaculada de la Torre; Kevin Winthrop; Robert L Gottlieb
Journal:  Nat Rev Immunol       Date:  2021-04-19       Impact factor: 108.555

7.  Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses.

Authors:  Jianhua Sui; William C Hwang; Sandra Perez; Ge Wei; Daniel Aird; Li-mei Chen; Eugenio Santelli; Boguslaw Stec; Greg Cadwell; Maryam Ali; Hongquan Wan; Akikazu Murakami; Anuradha Yammanuru; Thomas Han; Nancy J Cox; Laurie A Bankston; Ruben O Donis; Robert C Liddington; Wayne A Marasco
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

Review 8.  Antibodies in HIV-1 vaccine development and therapy.

Authors:  Florian Klein; Hugo Mouquet; Pia Dosenovic; Johannes F Scheid; Louise Scharf; Michel C Nussenzweig
Journal:  Science       Date:  2013-09-13       Impact factor: 47.728

Review 9.  Passive immunotherapy of viral infections: 'super-antibodies' enter the fray.

Authors:  Laura M Walker; Dennis R Burton
Journal:  Nat Rev Immunol       Date:  2018-01-30       Impact factor: 53.106

10.  Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus.

Authors:  Moritz U G Kraemer; Robert C Reiner; Oliver J Brady; Jane P Messina; Marius Gilbert; Simon I Hay; Nick Golding; David M Pigott; Dingdong Yi; Kimberly Johnson; Lucas Earl; Laurie B Marczak; Shreya Shirude; Nicole Davis Weaver; Donal Bisanzio; T Alex Perkins; Shengjie Lai; Xin Lu; Peter Jones; Giovanini E Coelho; Roberta G Carvalho; Wim Van Bortel; Cedric Marsboom; Guy Hendrickx; Francis Schaffner; Chester G Moore; Heinrich H Nax; Linus Bengtsson; Erik Wetter; Andrew J Tatem; John S Brownstein; David L Smith; Louis Lambrechts; Simon Cauchemez; Catherine Linard; Nuno R Faria; Oliver G Pybus; Thomas W Scott; Qiyong Liu; Hongjie Yu; G R William Wint
Journal:  Nat Microbiol       Date:  2019-03-04       Impact factor: 17.745
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.